EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies

Mohamed El-Tanani iD, Syed Arman Rabbani iD, Shakta Mani Satyam iD, Imran Rashid Rangraze iD, Adil Farooq Wali iD, Yahia El-Tanani, Alaa A A Aljabali iD

Cancers · 24.01.2025 · 17 (3) · 382

DOI: 10.3390/cancers17030382 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 24.01.2025. Verfasst von Mohamed El-Tanani und 6 weiteren Autor:innen. Beteiligte Einrichtung: RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) play a central role in tumor progression, recurrence, and resistance to conventional therapies, making them a critical focus in oncology research. This review provides a comprehensive analysis of CSC biology, emphasizing their self-renewal, differentiation, and dynamic interactions with the tumor microenvironment (TME). Key signaling pathways, including Wnt, Notch, and Hedgehog, are discussed in detail to highlight their potential as therapeutic targets. Current methodologies for isolating CSCs are critically examined, addressing their advantages and limitations in advancing precision medicine. Emerging technologies, such as CRISPR/Cas9 and single-cell sequencing, are explored for their transformative potential in unraveling CSC heterogeneity and informing therapeutic strategies. The review also underscores the pivotal role of the TME in supporting CSC survival, promoting metastasis, and contributing to therapeutic resistance. Challenges arising from CSC-driven tumor heterogeneity and dormancy are analyzed, along with strategies to mitigate these barriers, including novel therapeutics and targeted approaches. Ethical considerations and the integration of artificial intelligence in designing CSC-specific therapies are discussed as essential elements of future research. The manuscript advocates for a multi-disciplinary approach that combines innovative technologies, advanced therapeutics, and collaborative research to address the complexities of CSCs. By bridging existing gaps in knowledge and fostering advancements in personalized medicine, this review aims to guide the development of more effective cancer treatment strategies, ultimately improving patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecancer stem cellssignaling pathwaystherapeutic resistancetumor heterogeneitytumor microenvironment

Autor:innen und Institutionen

  • RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.
  • Department of Clinical Pharmacy, RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.
  • Department of Pharmacology, RAK College of Medical Sciences, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.
  • Department of Internal Medicine, RAK College of Medical Sciences, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.
  • Department of Medicinal Chemistry, RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah P.O. Box 11172, United Arab Emirates.
  • Royal Cornwall Hospital NHS Trust, Truro TR1 3LJ, UK.

ORCID-Profile: Mohamed El-Tanani, Syed Arman Rabbani, Shakta Mani Satyam, Imran Rashid Rangraze, Adil Farooq Wali, Alaa A A Aljabali

Zitieren

APA

El-Tanani, M., Rabbani, S. A., Satyam, S. M., Rangraze, I. R., Wali, A. F., El-Tanani, Y., & Aljabali, A. A. A. (2025). Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies. Cancers, 17(3), 382. https://doi.org/10.3390/cancers17030382

Vancouver

El-Tanani M, Rabbani SA, Satyam SM, Rangraze IR, Wali AF, El-Tanani Y, et al. Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies. Cancers. 2025;17(3):382. doi:10.3390/cancers17030382

BibTeX
@article{ElTanani2025,
  author = {El-Tanani, Mohamed and Rabbani, Syed Arman and Satyam, Shakta Mani and Rangraze, Imran Rashid and Wali, Adil Farooq and El-Tanani, Yahia and Aljabali, Alaa A A},
  title = {Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {382},
  doi = {10.3390/cancers17030382}
}
Kostenlos starten →